Hamre, Harald J.Witt, Claudia M.Kienle, Gunver S.Schnürer, ChristofGlockmann, AnjaZiegler, RenatusWillich, Stefan N.Kiene, Helmut2024-05-232024-05-232009Hamre, H. J., Witt, C. M., Kienle, G. S., Schnürer, C., Glockmann, A., Ziegler, R., Willich, S. N., & Kiene, H. (2009). Anthroposophic therapy for asthma: A two-year prospective cohort study in routine outpatient settings. Journal of Asthma and Allergy, 2, 111–128. https://doi.org/10.2147/jaa.s12187487https://doi.org/10.2147/jaa.s12187487https://hdl.handle.net/20.500.14430/610<p><strong>Background</strong>: Anthroposophic treatment for asthma includes special artistic and physical therapies and special medications.<br /><strong>Methods</strong>: We studied consecutive outpatients starting anthroposophic treatment for asthma under routine conditions in Germany. Main outcomes were average asthma severity (0–10, primary outcome); symptoms (1–4); and asthma-related quality of life at 12-month follow-up (Asthma Quality of Life Questionnaire [AQLQ] overall score, 1–7, for adults; KINDL Questionnaire for Measuring Health-Related Quality of Life in Children and Adolescents, asthma module, 0–100, for children) at 12-month follow-up.<br /><strong>Results</strong>: Ninety patients (54 adults, 36 children) were included. Anthroposophic treatment modalities used were medications (88% of patients, n = 79/90); eurythmy therapy (22%); art therapy (10%); and rhythmical massage therapy (1%). Median number of eurythmy/art/massage sessions was 12 (interquartile range 10–20), median therapy duration was 120 days (84–184). From baseline to 12-month follow-up, all outcomes improved significantly (P ? 0.001 for all comparisons). Average improvements were: average asthma severity 2.61 points (95% confidence interval CI: 1.90–3.32); cough 0.93 (95% CI: 0.60–1.25); dyspnea 0.92 (95% CI: 0.56–1.28); exertion-induced symptoms 0.95 (95% CI: 0.64–1.25); frequency of asthma attacks 0.78 (95% CI: 0.41–1.14); awakening from asthma 0.90 (95% CI: 0.58–1.21); AQLQ overall score 1.44 (95% CI: 0.97–1.92); and KINDL asthma module 14.74 (95% CI: 9.70–19.78). All improvements were maintained until last follow-up after 24 months.<br /><strong>Conclusions</strong>: Patients with asthma under anthroposophic treatment had long-term improvements of symptoms and quality of life.<br /><strong>Keywords</strong>: anthroposophy, art therapy, asthma, combined modality therapy, drug therapy, eurythmy therapy, prospective studies, quality of life</p> <p><strong>Citation</strong>: Hamre, H. J., Witt, C. M., Kienle, G. S., Schnürer, C., Glockmann, A., Ziegler, R., Willich, S. N., &amp; Kiene, H. (2009). Anthroposophic therapy for asthma: A two-year prospective cohort study in routine outpatient settings. <em>Journal of Asthma and Allergy</em>, <em>2</em>, 111–128. <a href="https://doi.org/10.2147/jaa.s12187487" target="_blank">https://doi.org/10.2147/jaa.s12187487</a></p>heracleum mantegazianumtabacum cupro cultumargentum/echinaceasymptom improvementQOL improvementArt therapyComplementary AM therapyEurythmy therapy/library/2019/1/7/anthroposophic-therapy-for-asthma